Sandipkumar Patel

410 total citations
20 papers, 249 citations indexed

About

Sandipkumar Patel is a scholar working on Oncology, Surgery and Genetics. According to data from OpenAlex, Sandipkumar Patel has authored 20 papers receiving a total of 249 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 4 papers in Surgery and 3 papers in Genetics. Recurrent topics in Sandipkumar Patel's work include Cancer Immunotherapy and Biomarkers (8 papers), Frailty in Older Adults (3 papers) and Lung Cancer Research Studies (3 papers). Sandipkumar Patel is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Frailty in Older Adults (3 papers) and Lung Cancer Research Studies (3 papers). Sandipkumar Patel collaborates with scholars based in United States, United Kingdom and India. Sandipkumar Patel's co-authors include Gregory A. Otterson, Dwight H. Owen, Kari Kendra, Faisal S. Ali, Rita Chiari, Abdul Rafeh Naqash, Jiajia Zhang, Pauline Funchain, Jianjun Gao and Joseph Sleiman and has published in prestigious journals such as Journal of Clinical Oncology, The American Journal of Medicine and The Oncologist.

In The Last Decade

Sandipkumar Patel

16 papers receiving 249 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandipkumar Patel United States 7 190 55 45 42 35 20 249
Yuequan Shi China 10 170 0.9× 89 1.6× 60 1.3× 32 0.8× 19 0.5× 27 265
Anne Laure Voisin France 2 271 1.4× 103 1.9× 46 1.0× 24 0.6× 22 0.6× 2 295
Yan-Ping Mao China 2 364 1.9× 125 2.3× 94 2.1× 25 0.6× 52 1.5× 2 417
John M. Richart United States 8 154 0.8× 59 1.1× 109 2.4× 28 0.7× 50 1.4× 21 280
Seigo Sasaki Japan 4 289 1.5× 153 2.8× 47 1.0× 32 0.8× 36 1.0× 8 326
Osamu Hiranuma Japan 10 261 1.4× 174 3.2× 41 0.9× 38 0.9× 35 1.0× 34 342
Kenta Nio Japan 7 117 0.6× 37 0.7× 35 0.8× 39 0.9× 36 1.0× 28 169
Maria Anna Siciliano Italy 7 80 0.4× 55 1.0× 26 0.6× 27 0.6× 26 0.7× 12 176
Judicaël Hotton France 8 101 0.5× 39 0.7× 19 0.4× 17 0.4× 35 1.0× 23 215
Barbara Sosnowska‐Pasiarska Poland 8 94 0.5× 36 0.7× 57 1.3× 17 0.4× 14 0.4× 18 201

Countries citing papers authored by Sandipkumar Patel

Since Specialization
Citations

This map shows the geographic impact of Sandipkumar Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandipkumar Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandipkumar Patel more than expected).

Fields of papers citing papers by Sandipkumar Patel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandipkumar Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandipkumar Patel. The network helps show where Sandipkumar Patel may publish in the future.

Co-authorship network of co-authors of Sandipkumar Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Sandipkumar Patel. A scholar is included among the top collaborators of Sandipkumar Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandipkumar Patel. Sandipkumar Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chowdhury, Tahseen A, et al.. (2025). Role of Artificial Intelligence in the Diagnosis of Oral Squamous Cell Carcinoma: A Systematic Review. Cureus. 17(4). e81800–e81800. 4 indexed citations
2.
3.
Tedeschi, Alessandra, Inhye E. Ahn, Graeme Fraser, et al.. (2023). Ibrutinib (Ibr) dose modification for management of early cardiac adverse events in patients with chronic lymphocytic leukemia: Pooled analysis of 7 clinical trials. Hematological Oncology. 41(S2). 461–463.
4.
Johns, Andrew, Lai Wei, Madison Grogan, et al.. (2023). Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with Cancer. The Oncologist. 28(8). e625–e632. 7 indexed citations
5.
Johns, Andrew, Lai Wei, Madison Grogan, et al.. (2023). Association of medical comorbidities and cardiovascular disease with toxicity and survival among patients receiving checkpoint inhibitor immunotherapy. Cancer Immunology Immunotherapy. 72(7). 2005–2013. 7 indexed citations
6.
Patel, Sandipkumar, et al.. (2022). Glycated hemoglobin and fructosamine level in complicated and non-complicated chronic alcoholic liver disease. National Journal of Physiology Pharmacy and Pharmacology. 1–1. 1 indexed citations
7.
8.
Johns, Andrew, Lai Wei, Madison Grogan, et al.. (2021). Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancer. Journal of Geriatric Oncology. 12(5). 813–819. 27 indexed citations
9.
Husain, Marium, Menglin Xu, Sandipkumar Patel, et al.. (2021). Proton pump inhibitor use (PPI) in patients treated with immune checkpoint inhibitors (ICI) for advanced cancer: Survival and prior therapy.. Journal of Clinical Oncology. 39(15_suppl). 2633–2633. 9 indexed citations
10.
Patel, Sandipkumar, Lai Wei, Erin M. Bertino, et al.. (2021). P21.02 Incidence and Outcomes of Brain Metastases in Unresectable Stage III Patients with NSCLC Treated with Durvalumab after Chemoradiation. Journal of Thoracic Oncology. 16(3). S363–S364.
11.
Husain, Marium, Menglin Xu, Sandipkumar Patel, et al.. (2021). P40.15 Proton Pump Inhibitors, Prior Therapy and Survival in Patients Treated With Immune Checkpoint Inhibitors for Advanced NSCLC. Journal of Thoracic Oncology. 16(10). S1076–S1076. 3 indexed citations
12.
Johns, Andrew, Lai Wei, Madison Grogan, et al.. (2020). Association of medical comorbidities and cardiovascular disease with toxicity and survival in patients receiving checkpoint inhibitor immunotherapy.. Journal of Clinical Oncology. 38(15_suppl). 7039–7039. 5 indexed citations
13.
Patel, Sandipkumar, et al.. (2020). Molecular Complete Remission Following Ivosidenib in a Patient With an Acute Undifferentiated Leukemia. Journal of the National Comprehensive Cancer Network. 18(1). 6–10. 5 indexed citations
14.
Owen, Dwight H., Sandipkumar Patel, Lai Wei, et al.. (2019). Metastatic Adrenocortical Carcinoma: a Single Institutional Experience. Hormones and Cancer. 10(4-6). 161–167. 13 indexed citations
15.
Abu‐Sbeih, Hamzah, Faisal S. Ali, Abdul Rafeh Naqash, et al.. (2019). Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis. Journal of Clinical Oncology. 37(30). 2738–2745. 149 indexed citations
16.
Johns, Andrew, Madison Grogan, Rebecca Hoyd, et al.. (2019). Is immunotherapy toxicity associated with improved overall survival among older adults with advanced cancer?. Journal of Clinical Oncology. 37(15_suppl). 6580–6580. 1 indexed citations
17.
18.
Shukuya, Takehito, Sandipkumar Patel, Kate Shane-Carson, et al.. (2017). Lung Cancer Patients with Germline Mutations Detected by Next-Generation Sequencing and/or Liquid Biopsy. Journal of Thoracic Oncology. 13(2). e17–e19. 10 indexed citations
19.
Patel, Sandipkumar, Dwight H. Owen, Carl Schmidt, et al.. (2017). Favorable and Durable Response to Pazopanib in Metastatic Refractory Paraganglioma. Journal of Oncology Practice. 13(12). 840–842. 3 indexed citations
20.
Patel, Sandipkumar, et al.. (2015). Common Symptoms with Rare Entity: A Giant Pericardial Cyst. The American Journal of Medicine. 128(10). e27–e28. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuequan Shi Breakdown of academic impact, for papers by Anne Laure Voisin Breakdown of academic impact, for papers by Yan-Ping Mao Breakdown of academic impact, for papers by John M. Richart Breakdown of academic impact, for papers by Seigo Sasaki Breakdown of academic impact, for papers by Osamu Hiranuma Breakdown of academic impact, for papers by Kenta Nio Breakdown of academic impact, for papers by Maria Anna Siciliano Breakdown of academic impact, for papers by Judicaël Hotton Breakdown of academic impact, for papers by Barbara Sosnowska‐Pasiarska
Rankless by CCL
2026